Trials / Completed
CompletedNCT00768638
Study of Atorvastatin Dose Dependent Reduction of Proteinuria
The Renal Protective Effects of Low-dose and High-dose Atorvastatin in Patients With Glomerular Disease and Proteinuria: a Randomized Controlled Double Blinded Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Laval University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Randomized controlled double blind study of parallel groups to evaluate the comparative effects of low-dose of atorvastatin on proteinuria in patients with stage 3 or 4 chronic kidney disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin | Atorvastatin 10mg 1co id (10mg active) Placebo 40mg 1co id (40mg inactive) |
| DRUG | Atorvastatin | Atorvastatin 40mg 1co id (40mg active) Placebo 10mg 1co id (10mg inactive) |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2014-05-01
- Completion
- 2014-06-01
- First posted
- 2008-10-08
- Last updated
- 2015-04-29
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00768638. Inclusion in this directory is not an endorsement.